The resurgence of psychedelic research is occurring in the context of an enormous burden of untreated and refractory mental illness in the US and abroad. Classical psychedelics have yet to be approved for the treatment of any illness in the United States and are presently illegal (designated as ‘Schedule 1’ substances by the DEA). However, preliminary data suggests that psychedelic-assisted treatments may be effective for some of our most prevalent, debilitating, and fatal conditions. If ongoing research continues to show efficacy, there may be a public health imperative to advance our understanding and application of these treatments.
Below is a brief list of mental health conditions with significant consequence for individual and public health, and the corresponding evidence suggesting benefit from psychedelic-assisted treatments.
(Disclaimer: neither Stanford nor SPSG condones illicit substance use; all discussion of psychedelics on this website and in this group is in the context of sanctioned research)